Outcome of fetuses with prenatal diagnosis of isolated severe bilateral ventriculomegaly: systematic review and meta‐analysis
Open Access
- 26 February 2018
- journal article
- review article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 52 (2) , 165-173
Abstract
Objective: To quantify from the published literature survival and neurodevelopmental outcome of fetuses with prenatally detected isolated severe bilateral ventriculomegaly.Methods: MEDLINE, EMBASE and the Cochrane Library were searched electronically. Only cases with a prenatal diagnosis of apparently isolated severe ventriculomegaly and postnatal neurodevelopmental assessment were selected and included. Severe ventriculomegaly was defined as enlargement of the ventricular atria, with a diameter of greater than 15 mm in the transventricular plane. All cases in which the investigators were unable to detect associated structural abnormality, chromosomal abnormality or fetal infection, and in which the ventriculomegaly was therefore regarded as apparently isolated, were included. Those for which the etiology was identified prenatally were excluded, whereas those with postnatal identification of the underlying cause were not excluded, since this information was not available prenatally. The quality of the included studies was assessed using the Newcastle–Ottawa Scale (NOS) for cohort studies. Pregnancy outcomes such as termination, stillbirth, neonatal survival and developmental outcome of the baby, were recorded. The degree of disability was classified as no, mild or severe disability. Statistical assessment was performed by meta‐analysis of proportions to combine data, weighting the studies using the inverse variance method and a random‐effects model. Proportions and CIs were reported.Results: Eleven studies including 137 fetuses were found. Twenty‐seven pregnancies underwent termination and were excluded. The remaining 110 fetuses with apparently isolated severe ventriculomegaly for which continuation of pregnancy was intended, form the study population. Overall quality assessed using NOS for cohort studies was good. Survival was reported in 95/110 (pooled proportion 87.9% (95% CI, 75.6–96.2%)) cases. In 15/110 (pooled proportion 12.1% (95% CI, 3.8–24.4%)), either stillbirth or neonatal demise was reported. No disability was reported in 41/95 survivors (pooled proportion 42.2% (95% CI, 27.5–57.6%)). However, 17/95 showed mild/moderate disability (pooled proportion 18.6% (95% CI, 7.2–33.8%)) and 37/95 were reported to have severe disability (pooled proportion 39.6% (95% CI, 30.0–50.0%)).Conclusions: Four‐fifths of fetuses with severe ventriculomegaly survive and, of these, just over two‐fifths show normal neurodevelopment. The overall survivors without disability account for more than one third of the total. Given that many cases undergo termination of pregnancy and require longer follow‐up in order to detect subtle abnormalities, mortality and prevalence of developmental delay may be even higher than that reported in this paper. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.Keywords
This publication has 30 references indexed in Scilit:
- From Karyotyping to Array-CGH in Prenatal DiagnosisCytogenetic and Genome Research, 2011
- How to write a Cochrane systematic reviewNephrology, 2010
- Prevalence, Characteristics and Perinatal Outcome of Fetal Ventriculomegaly in 29,000 Pregnancies Followed at a Single InstitutionFetal Diagnosis and Therapy, 2010
- Natural history of apparently isolated severe fetal ventriculomegaly: perinatal survival and neurodevelopmental outcomePrenatal Diagnosis, 2009
- Sonographic diagnosis of fetal cerebral ventriculomegaly: An updateThe Journal of Maternal-Fetal & Neonatal Medicine, 2007
- Obstetric and neonatal outcomes in severe fetal ventriculomegalyPrenatal Diagnosis, 2006
- The case of the misleading funnel plotBMJ, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Mild Fetal Cerebral Ventriculomegaly: Diagnosis, Clinical Associations, and OutcomesObstetrical & Gynecological Survey, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002